Intravenous Human Plasma Immunoglobulin Medicine
Original notice title
Belgium – Pharmaceutical products – Spécialité pharmaceutique à base d'immunoglobulines issues du plasma humain à administration IV
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 3 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Healthcare Public Procurement (HeCaPP)
- Country
- Belgium
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Nov 23, 2026
AI tender analysis
Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.
Award Criteria
Lot 1
Buyer
Location
Saint-Gilles\Sint-Gillis, BEL
Website
Buyer profile
Identifier
BE0479886021
Activity
Health
Lots (1)
LOT-0001
Spécialité pharmaceutique à base d'immunoglobulines issues du plasma humain à administration IV
Spécialité pharmaceutique à base d'immunoglobulines issues du plasma humain à administration IV
Location
Duration
Category
Award Criteria
Award details
Prix
Procurement Details
- Publication date
- 16 Nov 2026
- Languages
- French
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 797524-2026
Documents (2)
Similar tenders
Poland – Pharmaceutical products – Dostawa produktów leczniczych Programy lekowe
Sweden – Pharmacy services – Läkemedelsförsörjning till primärvård, folktandvård, öppenvårdsmottagning samt SÄBO
Sweden – Medical equipments, pharmaceuticals and personal care products – Rekvisitionsläkemedel - Parenteral Nutrition 2027
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Brinzolamid und Brimonidin (ATC-Code: S01EC24).
Portugal – Pharmaceutical products – 141000727 - Aquisição de Desinfetantes de Material e Soluções para Conservação Órgãos (GR 20, 20.5 e 20.6), 2027
Poland – Pharmaceutical products – 315/PN/2026 - Dostawa produktów leczniczych dla UCK
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 3 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications